SCHEMBL17243911

SCHEMBL17243911

C=C/C(=C\C=C/C)S(=O)(=O)c1cccc(-n2nc(C(=O)OCC)c(=O)c3cccnc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.39
ALDH1A1 P00352 7/20 0.36
ADORA1 P30542 3/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
MAPT P10636 2/20 0.34
APP P05067 1/20 0.34
UBE2N P61088 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MAPK8 P45983 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA9 Q16790 1/20 0.33
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
CASP1 P29466 1/20 0.33
BRD4 O60885 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17243910 0.89 MAP3K14 (0.34) ALDH1A1KDM4EMAPK8PKD1MAP3K14
SCHEMBL17243623 0.78 ELANE (0.42) ELANEALDH1A1ADORA1HTTKDM4E
SCHEMBL17233527 0.77 PDE4A (0.51) ELANEALDH1A1ADORA1HTTKDM4E
SCHEMBL17233520 0.72 ELANE (0.44) ELANEALDH1A1ADORA1HTTKDM4E
SCHEMBL16532310 0.70 ELANE (0.56) ELANEALDH1A1ADORA1KDM4EHSD17B10
SCHEMBL17243618 0.68 ELANE (0.52) ELANEKDM4EBRD4
SCHEMBL17243924 0.67 PDE4A (0.45) PKD1MAP3K14
SCHEMBL17243915 0.65 PDE4A (0.42) PKD1MAP3K14
SCHEMBL17243622 0.64 PDE4A (0.40) ALDH1A1KDM4EMAPK8CA1CA2
SCHEMBL13070650 0.63 ALDH1A1 (0.52) ALDH1A1ADORA1HTTKDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9181244-B1 Substituted pyrido[2,3-c]pyridazin-4(1H)-ones as tumor necrosis factor alpha and phosphodiesterase 4 inhibitors Xuanzhu Pharma Co., Ltd. (CN) 2015-11-10 US disclosed